In this study, based on the analysis of TCGA database, we demonstrated that down‐regulated B4GALT1 in high‐grade, lymph‐node metastatic and biochemical recurrent PCa tissues predicts a poor prognosis of patients, indicating its role as a novel tumour suppressor in PCa. This evidence concerns the gene B4GALT1 and neoplasm.